Recent Finacing
Recent Raise
Flashpoint Therapeutics develops a nanostructure-based platform to kinetically tune and co-deliver controlled-stoichiometry RNA, peptide, and CRISPR therapeutics to target immune cells and brain tissue.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
